JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1677/joe.0.173R009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Florio, P
Right arrow Articles by Petraglia, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Florio, P
Right arrow Articles by Petraglia, F
Journal of Endocrinology, Vol 173, Issue 2, R9-14
Copyright © 2002 by Society for Endocrinology

Articles

Identification of urocortin mRNA and peptide in the human endometrium

P Florio, F Arcuri, P Ciarmela, Y Runci, R Romagnoli, M Cintorino, AM Di Blasio, and F Petraglia


Urocortin is a 40-amino acid peptide belonging to the corticotropin-releasing factor (CRF) family. In human reproductive tissues, urocortin expression has been previously demonstrated in the ovary, in the placenta and fetal membranes and in pregnant uterine tissues, while no data are available on the expression of the peptide in the nonpregnant uterus. In this study, urocortin expression was evaluated by both immunohistochemistry and reverse transcription-polymerase chain reaction, in human uterine tissues and cells at different phases of the menstrual cycle. Urocortin was immunolocalized in endometrial epithelial and stromal cells, as well as in the myometrium, and in vascular smooth muscle cells. No differences between proliferative and secretory phase were observed. These results were confirmed by reverse transcription-polymerase chain reaction analysis of isolated endometrial epithelial and stromal cells, and myometrial specimens. These findings open new questions on the roles played by urocortin in the human uterus.


This article has been cited by other articles:


Home page
 Obstet GynecolHome page
P. Florio, F. M. Reis, P. B. Torres, F. Calonaci, P. Toti, C. Bocchi, E. A. Linton, and F. Petraglia
Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis
Obstet. Gynecol., September 1, 2007; 110(3): 594 - 600.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. T. Rademaker, C. J. Charles, and A. M. Richards
Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1536 - H1544.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Torricelli, G. De Falco, P. Florio, M. Rossi, E. Leucci, P. Vigano, L. Leoncini, and F. Petraglia
Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process
Hum. Reprod., January 1, 2007; 22(1): 92 - 96.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
P. Florio, G. De Falco, E. Leucci, M. Torricelli, P. B Torres, P. Toti, A. Dell'Anna, E. Tiso, R. Santopietro, L. Leoncini, et al.
Urocortin expression is downregulated in human endometrial carcinoma.
J. Endocrinol., July 1, 2006; 190(1): 99 - 105.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.